Arcus Biosciences, Inc.

Stephen Edmund Gottschling

Eric F Connor

Andrew M K Pennell

Jim Dimetrios Colomvakos

Mohammed Asadullah Khan

Crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, ecto, and compositions containing the compound and methods for preparing the crystalline forms, are described herein. The use of such crystalline form of Formula (I) and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer and immune-related disorders, that are mediated by 5′-nucleotidase, ecto is also provided.

Crystalline forms of a CD73 inhibitor and uses thereof

Crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, ecto, and compositions containing the compound and methods for preparing the crystalline forms, are described herein. The use of such crystalline form of Formula (I) and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer and immune-related disorders, that are mediated by 5&#x2032;-nucleotidase, ecto is also provided.

Growing community of inventors

Bolton, Canada

Stephen Edmund Gottschling